The regional treatment of liver metastases from breast cancer
- 1 January 1994
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 55 (1), 26-32
- https://doi.org/10.1002/jso.2930550108
Abstract
To determine the effect of aggressive regional therapy for liver metastasis from breast cancer, we retrospectively reviewed data on 74 patients identified with liver metastases. Forty had only liver metastases. In this group of 40 patients, 18 were treated with regional therapy only, i.e., surgical resection and/or regional chemotherapy via hepatic artery or portal vein catheters whereas 22 patients had systemic chemotherapy. The two groups were comparable. The regional chemotherapy regimen was 5‐FU, Adriamycin, methotrexate, and cytoxan. Median survival (27 months) for those patients treated with regional therapy (N = 18) was significantly longer than for those (N = 22) treated with systemic therapy (5 months) (P = 0.001). Only 45% of the regional treatment group failed in the liver. Our data, although retrospective and selective, suggest that certain subgroups of breast cancer patients with metastatic liver disease may benefit from aggressive regional therapy. © Wiley‐Liss, Inc.Keywords
This publication has 10 references indexed in Scilit:
- Results of Surgical Excision of One to 13 Hepatic Metastases in 98 Consecutive PatientsArchives of Surgery, 1989
- Major Hepatic Resection A 25-Year ExperienceAnnals of Surgery, 1983
- Liver metastasesCurrent Problems in Surgery, 1981
- Causes of death in breast cancer a clinicopathologic studyCancer, 1980
- Treatment of hepatic metastases by percutaneous hepatic arterial infusionCancer, 1979
- Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycinCancer, 1979
- A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group projectCancer, 1977
- Tumor Vascularity as a Prognostic Factor for Hepatic TumorsAnnals of Surgery, 1977
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972
- Classification of patients with disseminated cancer of the breastCancer, 1969